Viewing Study NCT04080856


Ignite Creation Date: 2025-12-24 @ 11:24 PM
Ignite Modification Date: 2026-02-02 @ 8:43 AM
Study NCT ID: NCT04080856
Status: COMPLETED
Last Update Posted: 2022-09-28
First Post: 2019-09-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Real-World Experience Study of Elagolix For the Treatment of Endometriosis in Canada
Sponsor: AbbVie
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2019-12-04
Start Date Type: ACTUAL
Primary Completion Date: 2021-09-27
Primary Completion Date Type: ACTUAL
Completion Date: 2021-09-27
Completion Date Type: ACTUAL
First Submit Date: 2019-09-04
First Submit QC Date: None
Study First Post Date: 2019-09-06
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2022-09-26
Last Update Post Date: 2022-09-28
Last Update Post Date Type: ACTUAL